Paper167080
Prostaglandins and cutaneous inflammation.
Goldyne ME. J Invest Dermatol, 1975. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Prostaglandins and cutaneous inflammation. Papers, record 167080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/167080
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dermatitis | Major topic |
| Prostaglandins | Major topic |
| Animals | |
| Blood Platelets | |
| Blood Vessels | |
| Burns | |
| Chemical Phenomena | |
| Chemistry | |
| Chemotaxis | |
| Collagen | |
| Cyclic AMP | |
| Cyclic GMP | |
| Dermatitis, Contact | |
| Humans | |
| In Vitro Techniques | |
| Leukocytes | |
| Rabbits | |
| Radioimmunoassay | |
| Rats | |
| Skin |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34092255 | Effect of topical applications of sunflower seed oil on systemic fatty acid levels in under-two children under rehabilitation for severe acute malnutrition in Bangladesh: a randomized controlled trial. | Nutr J | 2021 | https://conductscience.org/library/papers/34092255 | PubMed |
| 32509290 | Topical emollient therapy in the management of severe acute malnutrition in children under two: A randomized controlled clinical trial in Bangladesh. | J Glob Health | 2020 | https://conductscience.org/library/papers/32509290 | PubMed |
| 7487139 | Prostaglandin I1 analogues, SM-10902 and SM-10906, affect human keratinocytes and fibroblasts in vitro in a manner similar to PGE1: therapeutic potential for wound healing. | Arch Dermatol Res | 1995 | https://conductscience.org/library/papers/7487139 | PubMed |
| 6267998 | [Angiotensin-converting enzyme (ACE). Increased serum activities in patients with dermatological diseases (author's transl)]. | Arch Dermatol Res | 1981 | https://conductscience.org/library/papers/6267998 | PubMed |
| 6167209 | Lipids and the epidermal permeability barrier. | Arch Dermatol Res | 1981 | https://conductscience.org/library/papers/6167209 | PubMed |
| 4050616 | Anti-inflammatory activity of orpanoxin administered orally and topically to rodents. | Agents Actions | 1985 | https://conductscience.org/library/papers/4050616 | PubMed |
| 1008999 | The role of prostaglandins in chemically induced inflammation. | Br J Exp Pathol | 1976 | https://conductscience.org/library/papers/1008999 | PubMed |
| 414528 | The effect of topically applied agents on ultraviolet erythema in guinea pigs. | Agents Actions | 1977 | https://conductscience.org/library/papers/414528 | PubMed |
| 332290 | Nonsteroidal anti-inflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses. | Can J Comp Med | 1977 | https://conductscience.org/library/papers/332290 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/167080
GET https://conductscience.org/api/papers/v1/167080/authors